Intra-cellular therapies announces expansion of its pipeline with the introduction of a new molecular entity, iti-1284

Iti-1284 is a deuterated form of lumateperone delivered sublingually as an orally disintegrating tablet (odt-sl). iti-1284 odt-sl may offer pharmacologic benefits and ease-of-use for patients, particularly in elderly populations.
ITCI Ratings Summary
ITCI Quant Ranking